Novel (1-piperidinylalkyl)pyrimidinone derivatives of the formula
the pharmaceutically acceptable acid-addition salts and the stereochemically isomeric forms thereof, which compounds are useful in the treatment of psychosomatic disorders; pharmaceutical compositions containing such compounds as an active ingredient and methods of preparing said compounds and pharmaceutical compositions.
新颖的(1-
哌啶基烷基)
嘧啶酮衍
生物,其式为
药学上可接受的酸加成盐及其立体异构体形式,这些化合物可用于治疗心身疾病;含有此类化合物作为活性成分的药物组合物,以及制备所述化合物和药物组合物的方法。